{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:59:28Z","timestamp":1787626768212,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bbrc.2023.149164","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T23:50:52Z","timestamp":1699314652000},"page":"149164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effect of combined administration of Acyl-CoA: Cholesterol acyltransferase 1 inhibitor and glucagon-like peptide 1 receptor agonist on a rodent model of diet-induced obesity"],"prefix":"10.1016","volume":"688","author":[{"given":"Sora Q.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9837-1496","authenticated-orcid":false,"given":"Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1124-572X","authenticated-orcid":false,"given":"Kee-Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.149164_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-2275(20)37830-5","article-title":"Adipose tissue and cholesterol metabolism","volume":"25","author":"Krause","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2023.149164_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00232-022-00263-9","article-title":"Cholesterol stiffening of lipid membranes","volume":"255","author":"Doole","year":"2022","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbrc.2023.149164_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9258(18)70543-7","article-title":"The esterification of cholesterol with palmitic acid by rat liver homogenates","volume":"230","author":"Mukherjee","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.149164_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1194\/jlr.M081745","article-title":"In vitro exploration of ACAT contributions to lipid droplet formation during adipogenesis","volume":"59","author":"Zhu","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2023.149164_bib5","doi-asserted-by":"crossref","first-page":"19306","DOI":"10.1074\/jbc.RA119.011160","article-title":"Enhanced acyl-CoA:cholesterol acyltransferase activity increases cholesterol levels on the lipid droplet surface and impairs adipocyte function","volume":"294","author":"Xu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.149164_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154861","article-title":"Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake","volume":"123","author":"Zhu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2023.149164_bib7","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.149164_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.bbrc.2023.149164_bib9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2023.149164_bib10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2023.149164_bib11","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/dom.13212","article-title":"Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: a comparative study between mice and non-human primates","volume":"20","author":"Elvert","year":"2018","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.bbrc.2023.149164_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2023.149164_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103202","article-title":"A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis","volume":"63","author":"Pan","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbrc.2023.149164_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114214","article-title":"Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents","volume":"233","author":"Yang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.149164_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34329-3","article-title":"Plasma lipidomic analysis reveals strong similarities between lipid fingerprints in human, hamster and mouse compared to other animal species","volume":"8","author":"Kaabia","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.149164_bib16","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/MCB.01321-14","article-title":"Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation","volume":"35","author":"Kim","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2023.149164_bib17","doi-asserted-by":"crossref","first-page":"R284","DOI":"10.1152\/ajpregu.00257.2017","article-title":"Adipose cell size: importance in health and disease","volume":"315","author":"Stenkula","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbrc.2023.149164_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between adipocyte size and adipokine expression and secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2023.149164_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2023.149164_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150607","article-title":"Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice","volume":"7","author":"Zhu","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2023.149164_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179558","article-title":"Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia","volume":"12","author":"Bandyopadhyay","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.149164_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/NEN.0b013e3181e77ed9","article-title":"The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice","volume":"69","author":"Huttunen","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2023.149164_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1194\/jlr.RA119000307","article-title":"Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism","volume":"61","author":"Straniero","year":"2020","journal-title":"J. Lipid Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23012585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23012585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:49:01Z","timestamp":1762094941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23012585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":23,"alternative-id":["S0006291X23012585"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149164","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of combined administration of Acyl-CoA: Cholesterol acyltransferase 1 inhibitor and glucagon-like peptide 1 receptor agonist on a rodent model of diet-induced obesity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.149164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"149164"}}